From BNA Health Care Daily Report
by Bronwyn Mixter
The HHS is reopening until May 19 the comment period on a proposed rule that would establish civil monetary penalties for drug manufacturers that charge safety-net providers too much for medications under a federal discount program.
Polsinelli's Travis Jackson
told Bloomberg BNA that "reopening the comment period strikes me as an attempt to reset the playing field between covered entities and manufacturers."
To read the full quote and article, click here